Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 27 Vincristine 24 Dexamethasone 22 Rituximab 21 Methotrexate 21 Cytarabine 21 Mercaptopurine 16 Doxorubicin 15 Etoposide 13 Asparaginase 13 Daunorubicin 12 Prednisone 10 Prednisolone 10 Granulocyte Colony-Stimulating Factor 10 Ifosfamide 8 Idarubicin 8 fludarabine 7 pegylated granulocyte colony-stimulating factor 6 Thioguanine 6 Teniposide 6 Vindesine 5 Brentuximab Vedotin 5 ibrutinib 4 fludarabine phosphate 4 Stem Cell Transplantation 4 Gemcitabine 4 Cisplatin 4 Aprepitant 4 zanubrutinib 3 prednylidene 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × fluarix × Lymphoid × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡